Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649946 · ClinicalTrials.gov registry record · NA
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT02649946: Completed NA study, sponsored by C. R. Bard.
NCT02649946 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 280 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02649946, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
The objective of this study is to assess the safety and effectiveness of the COVERA™ Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the Arteriovenous (AV) access circuit.
Primary Outcome
TLPP is defined as the interval following the index intervention until the next clinically driven reintervention at, or adjacent to,the original treatment site or until the extremity is abandoned for permanent access. Primary patency ends when any of the following occurs: a) clinically driven reintervention in the treatment area; b) thrombotic occlusion within the treatment area; c) surgical intervention that excludes the original treatment area from the AV circuit, and/or d) abandonment of the
Interventions
- DEVICE Covera Vascular Covered Stent following PTA
- PROCEDURE Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2016-06 |
| Est. Completion | 2021-02 |
| Phase | NA |
What the finished NCT02649946 record still lists
NCT02649946 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Covera Vascular Covered Stent following PTA is the first listed.
NCT02649946 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02649946 about?
NCT02649946 is a clinical study titled "Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft". The objective of this study is to assess the safety and effectiveness of the COVERA™ Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the Arteriovenous (AV) access circuit.
What is the current status of trial NCT02649946?
This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2016-06. Estimated completion is 2021-02.
What interventions are being tested in trial NCT02649946?
The interventions under investigation include: Covera Vascular Covered Stent following PTA (DEVICE), Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon (PROCEDURE).
Who is sponsoring clinical trial NCT02649946?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02649946's enrollment target sits among peer trials
280 380th of 2000 higher than 1,620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia